Sino Medical (China) Performance
| 688108 Stock | 10.86 0.36 3.43% |
Sino Medical has a performance score of 3 on a scale of 0 to 100. The entity has a beta of -0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sino Medical are expected to decrease at a much lower rate. During the bear market, Sino Medical is likely to outperform the market. Sino Medical Sciences right now has a risk of 2.48%. Please validate Sino Medical downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Sino Medical will be following its existing price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Medical Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Sino Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Ex Dividend Date 2020-07-10 |
1 | Hong Kong stock pharmaceutical ETF hit 3 consecutive gains, medical innovation ETF rose more than 1, and the transformation and implementation of medical scienc... | 03/05/2025 |
| Begin Period Cash Flow | 203.4 M |
Sino |
Sino Medical Relative Risk vs. Return Landscape
If you would invest 1,045 in Sino Medical Sciences on December 26, 2024 and sell it today you would earn a total of 41.00 from holding Sino Medical Sciences or generate 3.92% return on investment over 90 days. Sino Medical Sciences is generating 0.0975% of daily returns and assumes 2.4789% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Sino, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sino Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sino Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sino Medical Sciences, and traders can use it to determine the average amount a Sino Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0393
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 688108 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.48 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.1 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Sino Medical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sino Medical by adding it to a well-diversified portfolio.
Sino Medical Fundamentals Growth
Sino Stock prices reflect investors' perceptions of the future prospects and financial health of Sino Medical, and Sino Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sino Stock performance.
| Return On Equity | 0.0017 | ||||
| Return On Asset | -0.0247 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 4.4 B | ||||
| Shares Outstanding | 413.46 M | ||||
| Price To Book | 5.24 X | ||||
| Price To Sales | 9.75 X | ||||
| Revenue | 343.26 M | ||||
| Gross Profit | 458.74 M | ||||
| EBITDA | 31.95 M | ||||
| Net Income | (49.32 M) | ||||
| Total Debt | 69.27 M | ||||
| Book Value Per Share | 2.07 X | ||||
| Cash Flow From Operations | 56.84 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (234.73 M) | ||||
About Sino Medical Performance
By analyzing Sino Medical's fundamental ratios, stakeholders can gain valuable insights into Sino Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sino Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sino Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sino Medical is entity of China. It is traded as Stock on SHG exchange.Things to note about Sino Medical Sciences performance evaluation
Checking the ongoing alerts about Sino Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sino Medical Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 343.26 M. Net Loss for the year was (49.32 M) with profit before overhead, payroll, taxes, and interest of 458.74 M. | |
| About 34.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Hong Kong stock pharmaceutical ETF hit 3 consecutive gains, medical innovation ETF rose more than 1, and the transformation and implementation of medical science and technology achievements are highly anticipated - Yicai Global |
- Analyzing Sino Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sino Medical's stock is overvalued or undervalued compared to its peers.
- Examining Sino Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sino Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sino Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sino Medical's stock. These opinions can provide insight into Sino Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sino Stock analysis
When running Sino Medical's price analysis, check to measure Sino Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Medical is operating at the current time. Most of Sino Medical's value examination focuses on studying past and present price action to predict the probability of Sino Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Medical's price. Additionally, you may evaluate how the addition of Sino Medical to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |